These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 10304983)

  • 1. Informing women about 'The Pill'.
    FDA Consum; 1977 Feb; 11(1):20-1. PubMed ID: 10304983
    [No Abstract]   [Full Text] [Related]  

  • 2. Informing patients about drugs: a wrong way and a right way.
    Woodson DW
    Med World News; 1979 Jun; 20(13):6. PubMed ID: 10242286
    [No Abstract]   [Full Text] [Related]  

  • 3. Patient package inserts: a research perspective.
    Morris LA; Groft SC
    Drug Ther; 1982; ():191-217. PubMed ID: 7105993
    [No Abstract]   [Full Text] [Related]  

  • 4. Fact sheet on Therapeutic Nightmare and "the pill".
    Hardt RA
    West Med Med J West; 1966 Feb; 7(2):21-5. PubMed ID: 5951980
    [No Abstract]   [Full Text] [Related]  

  • 5. Myocardial infarction and the pill.
    Preston SN
    J Reprod Med; 1976 Jan; 16(1):1-4. PubMed ID: 1255638
    [No Abstract]   [Full Text] [Related]  

  • 6. The pill controversy.
    Records JW
    South Med J; 1970 May; 63(5):608-10. PubMed ID: 5467760
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA revises oral contraceptive labeling.
    Clin Pharm; 1987 Jul; 6(7):515. PubMed ID: 3691000
    [No Abstract]   [Full Text] [Related]  

  • 8. Patient package inserts.
    Morris LA
    JAMA; 1979 Mar; 241(12):1228. PubMed ID: 762781
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA acts on estrogen, progestin labeling.
    FDA Consum; 1977 Nov; 11(9):3. PubMed ID: 10305006
    [No Abstract]   [Full Text] [Related]  

  • 10. Developing drug information for patients.
    Hecht A
    FDA Consum; 1977 Sep; 11(7):16-9. PubMed ID: 10304999
    [No Abstract]   [Full Text] [Related]  

  • 11. Over (and behind) the counter. A deal is struck on selling the 'morning-after pill'--and a new FDA chief.
    Fischman J
    US News World Rep; 2006 Sep; 141(8):35. PubMed ID: 16981411
    [No Abstract]   [Full Text] [Related]  

  • 12. The legal status of patient package inserts.
    Whitman JA
    Hosp Formul; 1978 Oct; 13(10):789-91. PubMed ID: 10238809
    [No Abstract]   [Full Text] [Related]  

  • 13. Is the FDA packing a surprise for you?
    Chapman S
    Leg Aspects Med Pract; 1979 Nov; 7(11):35-8. PubMed ID: 263195
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug labeling and promotion: evolution and application of regulatory policy.
    Hayes TA
    Food Drug Law J; 1996; 51(1):57-73. PubMed ID: 11794353
    [No Abstract]   [Full Text] [Related]  

  • 15. Patient package inserts and oral contraceptives.
    Mayberger HW; Bell B
    J Leg Med (N Y); 1977 Sep; 5(9):14-7. PubMed ID: 302847
    [No Abstract]   [Full Text] [Related]  

  • 16. The patient package insert--an ethical dilemma.
    Braucher CL
    Am J Pharm Educ; 1981 Feb; 45(1):61-6. PubMed ID: 10251227
    [No Abstract]   [Full Text] [Related]  

  • 17. Antifertility drugs. Symposium discussion.
    Garcia CR
    Fed Proc; 1970; 29(3):1240-2. PubMed ID: 4910272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progestational drug products for human use; requirements for labeling directed to the patient. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 Nov; 64(220):62110-2. PubMed ID: 11010691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mandatory PPIs to begin in 1981; APhA issues strong objections.
    Small WE
    Am Pharm; 1980 Nov; NS20(11):10-1. PubMed ID: 7457342
    [No Abstract]   [Full Text] [Related]  

  • 20. Did FDA jump the gun?
    Archambault GF
    Hosp Formul; 1977 Oct; 12(10):722. PubMed ID: 10305387
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.